Celularity Inc. entered into a standby equity purchase agreement with new investor YA II PN, Ltd., a fund managed by Yorkville Advisors Global LP for issuance of class A common shares for gross proceeds of $10 million on March 13, 2024. The company will receive funding in 36 months period. The company paid to the investors $25,000 as cash due diligence fee and a commitment fee equal to 16,964 shares of common stock.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.31 USD | -9.07% | +10.70% | +33.79% |
1st Jan change | Capi. | |
---|---|---|
+33.79% | 79.29M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- CELU Stock
- News Celularity Inc.
- Celularity Inc. announced that it expects to receive $10 million in funding from Yorkville Advisors Global LP